Humacyte Inc (HUMA)
6.42
-0.05
(-0.77%)
USD |
NASDAQ |
May 16, 16:00
6.415
0.00 (0.00%)
After-Hours: 20:00
Humacyte Market Cap: 764.52M for May 16, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 764.52M |
| May 15, 2024 | 770.48M |
| May 14, 2024 | 764.52M |
| May 13, 2024 | 652.58M |
| May 10, 2024 | 559.70M |
| May 09, 2024 | 538.26M |
| May 08, 2024 | 537.07M |
| May 07, 2024 | 548.98M |
| May 06, 2024 | 540.64M |
| May 03, 2024 | 525.16M |
| May 02, 2024 | 523.97M |
| May 01, 2024 | 523.97M |
| April 30, 2024 | 466.81M |
| April 29, 2024 | 487.06M |
| April 26, 2024 | 475.15M |
| April 25, 2024 | 464.43M |
| April 24, 2024 | 454.90M |
| April 23, 2024 | 468.00M |
| April 22, 2024 | 440.61M |
| April 19, 2024 | 440.61M |
| April 18, 2024 | 427.51M |
| April 17, 2024 | 371.54M |
| April 16, 2024 | 364.40M |
| April 15, 2024 | 341.77M |
| April 12, 2024 | 342.96M |
| Date | Value |
|---|---|
| April 11, 2024 | 359.63M |
| April 10, 2024 | 356.06M |
| April 09, 2024 | 362.02M |
| April 08, 2024 | 369.16M |
| April 05, 2024 | 362.02M |
| April 04, 2024 | 371.54M |
| April 03, 2024 | 360.83M |
| April 02, 2024 | 353.68M |
| April 01, 2024 | 358.44M |
| March 28, 2024 | 370.35M |
| March 27, 2024 | 369.16M |
| March 26, 2024 | 365.59M |
| March 25, 2024 | 373.92M |
| March 22, 2024 | 394.17M |
| March 21, 2024 | 428.70M |
| March 20, 2024 | 410.58M |
| March 19, 2024 | 408.24M |
| March 18, 2024 | 410.58M |
| March 15, 2024 | 379.00M |
| March 14, 2024 | 369.64M |
| March 13, 2024 | 384.85M |
| March 12, 2024 | 387.19M |
| March 11, 2024 | 363.79M |
| March 08, 2024 | 394.21M |
| March 07, 2024 | 382.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
205.89M
Minimum
Nov 01 2023
1.750B
Maximum
Sep 01 2021
489.28M
Average
367.66M
Median
Market Cap Benchmarks
| Adial Pharmaceuticals Inc | 5.717M |
| Gritstone Bio Inc | 81.06M |
| Precision BioSciences Inc | 82.97M |
| Puma Biotechnology Inc | 212.73M |
| Revance Therapeutics Inc | 330.06M |
Market Cap Related Metrics
| Price to Book Value | 29.23 |
| Price | 6.42 |
| Earnings Yield | -15.58% |